A research team led by A/Prof Chamindie Punyadeera has developed two saliva based tests for detection of Head and Neck Squamous Cell Carcinoma (HNSCC) at an early stage.

We are seeking a partner to commercialise the MethDNA-Oral Test™ Kit to detect HNSCC. One application would be regular post-resection recurrence testing where the second primary rate in ex-smokers is 2 to 7% per year. Monitoring patients through GP accessed testing, rather than a clinical examination by a surgeon would save substantial costs.